The Division of Clinical Pharmacology provides a Royal College of Physicians and Surgeons of Canada accredited subspecialty residency training program. This is for applicants who are eligible for the FRCPC specialist certification. We are the largest adult Clinical Pharmacology Program in Canada.
The Clinical Pharmacology fellowship is a 2 year program. Applicants usually have completed 3 years of Internal Medicine in an accredited Canadian training program. We will also consider applicants who have completed core accredited training in Pediatrics as well. All applicants must be eligible for educational licensure in the province of Ontario. We will accept 1-2 new fellows each year.
We will also consider a Clinical Pharmacology + (another subspecialty, e.g. cardiology, rheumatology, respirology etc). This will be a 3 year program. At the end of the 3 years, the trainee will have dual subspecialty certification from the Royal College of Physicians and Surgeons. If an applicant is interested in this route our program director (Dr. Steven Gryn (Steven.Gryn@Lhsc.on.ca)) and the program director of the other subspecialty here at Schulich School of Medicine, Western University will need to be informed and both program directors have to agree to the request for the combined subspecialty training. Feel free to contact Dr. Gryn if you need more information.
Our program is intended to provide the trainee with a solid background in principles of drug action, drug-drug interactions, and the emerging field of Personalized Medicine. Specifically, the fellow will receive training and clinic experience in the following areas:
Incorporating the latest technologies in the area of pharmacogenomics and drug level analysis using LC-MS/MS technologies to delivering individualized care to our patients. Personalized Medicine Program is led by Dr. Richard Kim his team are involved in applying personalized medicine to the care of hospitalized patients as well as in the outpatient setting through his Personalized Medicine Clinic at the University Hospital.
Drs. Gryn, Dresser, Hackam, and Spence provide various levels of outpatient care relating to hypertension and stroke prevention.
Drs. Matsui and Rieder run a number of clinics relating to drug allergy and drugs in pregnancy at a clinic called Fetal Risk Assessment from Maternal Exposure (FRAME) Clinic
Our trainees will receive both didactic training as well as spend at least 1 month in Toronto working with the Ontario Poison Centre and their Toxicology program.
A number of our faculty conduct world class bench-to-bedside research. Our fellows will be involved in various research projects, attend conferences, and present research findings. In addition, tailored teaching by our faculty will be provided to our fellows on the topic of Pharmacokinetics and Drug Development.
An application for our residency program can be found on the CARMS website. If you have questions about our subspecialty residency training or research program, feel free to contact Dr. Steven Gryn.